Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Clinical and Translational Allergy

Fig. 2

From: Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study

Fig. 2

Serum levels of PAF (a) and PAF-AH (b) and PAF-AH to PAF ratio (c) in H1RA responders and H1RA non-responders among CSU patients. PAF platelet activating factor, PAF-AH platelet activating factor acetylhydrolase, H1RA histamine receptor 1 antagonist, CSU chronic spontaneous urticaria. p values were estimated using Mann–Whitney U-test

Back to article page